文献速递基础与转化研究

无创胃部标测设备定义的慢性恶心呕吐综合征患者的胃功能障碍

Gastric dysfunction in patients with chronic nausea and vomiting syndromes defined by a noninvasive gastric mapping device.
PubMed 文献 · Sci Transl Med · 2022-09-21

研究用无创体表胃部标测(BSGM)设备Gastric Alimetry评估43例慢性恶心呕吐综合征(NVS)患者与43名匹配对照的胃运动功能。患者餐后振幅降低、餐后/空腹功率比受损、慢波空间频率稳定性下降;62%患者BSGM正常但心理共病和焦虑评分更高,31%患者BSGM明显异常且生物标志物与症状相关。NVS症状重叠但存在不同潜在表型。

要点

  • NVS患者餐后胃电振幅中位数23.3微伏低于对照38.0微伏(P<0.001)。
  • 62%NVS患者BSGM正常,其心理共病43.5%高于对照7.7%(P=0.03)。
  • 31%NVS患者BSGM明显异常,生物标志物与恶心、疼痛等症状相关(r>0.35)。

核心结论

  • NVS患者症状重叠但BSGM揭示不同潜在表型,表型与症状相关,应指导临床管理和治疗试验设计。

研究设计与样本

  • 研究纳入43例NVS患者和43名匹配对照,使用Gastric Alimetry进行无创体表胃部标测(8×8电极,20毫米电极间距),包含30分钟空腹基线、482千卡餐食和4小时餐后记录。

主要发现

  • NVS患者餐后振幅中位数23.3微伏低于对照38.0微伏(P<0.001)。
  • NVS患者餐后/空腹功率比1.1低于对照1.6(P=0.02)。
  • NVS患者慢波空间频率稳定性13.6低于对照49.5(P<0.001)。
  • 62%NVS患者BSGM正常,其心理共病43.5%高于对照7.7%(P=0.03),焦虑评分中位数16.5高于对照13.0(P=0.035)。
  • 31%NVS患者BSGM明显异常,生物标志物与恶心、疼痛、过度饱胀、早饱、腹胀相关(所有r>0.35,P<0.05)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chronic nausea and vomiting syndromes (NVSs) are prevalent and debilitating disorders. Putative mechanisms include gastric neuromuscular disease and dysregulation of brain-gut interaction, but clinical tests for objectively defining gastric motor function are lacking. A medical device enabling noninvasive body surface gastric mapping (BSGM) was developed and applied to evaluate NVS pathophysiology. BSGM was performed in 43 patients with NVS and 43 matched controls using Gastric Alimetry (Alimetry), a conformable high-resolution array (8 × 8 electrodes; 20-mm interelectrode spacing), wearable reader, and validated symptom-logging app. Continuous measurement encompassed a fasting baseline (30 minutes), 482-kilocalorie meal, and 4-hour postprandial recording, followed by spectral and spatial biomarker analyses. Meal responses were impaired in NVS, with reduced amplitudes compared to controls (median, 23.3 microvolts versus 38.0 microvolts, P < 0.001), impaired fed-fasting power ratios (1.1 versus 1.6, P = 0.02), and disorganized slow waves (spatial frequency stability, 13.6 versus 49.5; P < 0.001). Two distinct NVS subgroups were evident with indistinguishable symptoms (all P > 0.05). Most patients (62%) had normal BSGM studies with increased psychological comorbidities (43.5% versus 7.7%; P = 0.03) and anxiety scores (median, 16.5 versus 13.0; P = 0.035). A smaller subgroup (31%) had markedly abnormal BSGM, with biomarkers correlating with symptoms (nausea, pain, excessive fullness, early satiety, and bloating; all r > 0.35, P < 0.05). Patients with NVS share overlapping symptoms but comprise distinct underlying phenotypes as revealed by a BSGM device. These phenotypes correlate with symptoms, which should inform clinical management and therapeutic trial design.

来源:Sci Transl Med,查看原文。版权归原作者所有。

引用

  1. Gharibans AA, Calder S, Varghese C, et al. Gastric dysfunction in patients with chronic nausea and vomiting syndromes defined by a noninvasive gastric mapping device. Sci Transl Med. 2022. PMID: 36130019. doi:10.1126/scitranslmed.abq3544

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。